investorscraft@gmail.com

Stock Analysis & ValuationMindWalk Holdings Corp. (HYFT)

Previous Close
$1.21
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)11.40842
Intrinsic value (DCF)4.69288
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

3204 - 4464 Markham St.
Victoria, BC V8Z 7X8
Canada
Phone: 604-806-0626
Industry: Biotechnology
Sector: Healthcare
CEO: Jennifer Lynne Bath
Full Time Employees: 102

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

HomeMenuAccount